{
    "root": "6a6db9ce-b8aa-4fa2-81cb-e3cfaab5f95b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Savella",
    "value": "20250304",
    "ingredients": [
        {
            "name": "MILNACIPRAN HYDROCHLORIDE",
            "code": "RNZ43O5WW5"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE CALCIUM",
            "code": "UTY7PDF93L"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "savella indicated management fibromyalgia . savella approved pediatric patients [ ( 8.4 ) ] .",
    "contraindications": "savella given orally without food . taking savella food may improve tolerability .",
    "warningsAndPrecautions": "50-mg tablets : white , oval-shaped , film-coated tablets , debossed \u201c fl \u201d one side \u201c 50 \u201d reverse side bottles approximately 1920 film-coated tablets , ndc 55154-4626-8 storage store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "\u2022 serotonin syndrome maois : maois intended treat psychiatric disorders savella within 5 days stopping treatment savella . savella within 14 days stopping maoi intended treat psychiatric disorders . addition , start savella patient treated linezolid intravenous methylene blue ( 4.1 , 5.2 ) .",
    "indications_original": "SAVELLA is indicated for the management of fibromyalgia.\u00a0\n                  SAVELLA is not approved for use in pediatric patients [see Use in Specific Populations (8.4)].",
    "contraindications_original": "SAVELLA is given orally with or without food.\n                  Taking SAVELLA with food may improve the tolerability of the drug.",
    "warningsAndPrecautions_original": "50-mg tablets:\n                     \n                  \n                  White, oval-shaped, film-coated tablets, debossed with \u201cFL\u201d on one side and \u201c50\u201d on the reverse\u00a0side\n                  Bottles of approximately 1920 film-coated tablets, NDC 55154-4626-8\n                  \n                     Storage\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted between 15\u00b0C and 30\u00b0C (between 59\u00b0F and 86\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "\u2022 Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with SAVELLA or within 5 days of stopping treatment with SAVELLA.  Do not use SAVELLA within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start SAVELLA in a patient who is being treated with linezolid or intravenous methylene blue ( 4.1 , 5.2 )."
}